44 related articles for article (PubMed ID: 21779772)
1. Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
Jamieson A; Grube M; Leung S; Chiu D; Lum A; Kwon JS; Talhouk A; Gilks B; Kommoss S; McAlpine JN
Int J Gynecol Cancer; 2024 Apr; 34(4):544-549. PubMed ID: 38388178
[TBL] [Abstract][Full Text] [Related]
2. Moving into the modern era of molecular classification for endometrial cancer.
Dagher C; Liu YL; Mueller JJ; Weigelt B
J Surg Oncol; 2024 Jan; 129(1):120-125. PubMed ID: 38100711
[TBL] [Abstract][Full Text] [Related]
3. Advancing endometrial cancer management in the era of molecular classification: insights into pattern of recurrence.
De Vitis LA; Multinu F
Int J Gynecol Cancer; 2024 May; 34(5):667-668. PubMed ID: 38589210
[No Abstract] [Full Text] [Related]
4. Uncommon Morphologic Types of Endometrial Cancer and Their Mimickers: How Much Does Molecular Classification Improve the Practice for Challenging Cases?
Saglam O
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541711
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of preoperative sampling diagnosis for predicting final pathology in patients with endometrial carcinoma: a review.
Lukanović D; Matjašič M; Kobal B
Transl Cancer Res; 2020 Dec; 9(12):7785-7796. PubMed ID: 35117381
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer.
Wang L; Zhou W; Li H; Yang H; Shan N
Front Oncol; 2020; 10():1468. PubMed ID: 32983981
[No Abstract] [Full Text] [Related]
7. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.
Helpman L; Kupets R; Covens A; Saad RS; Khalifa MA; Ismiil N; Ghorab Z; Dubé V; Nofech-Mozes S
Br J Cancer; 2014 Feb; 110(3):609-15. PubMed ID: 24366295
[TBL] [Abstract][Full Text] [Related]
8. Predictive and prognostic factors in definition of risk groups in endometrial carcinoma.
Sorbe B
ISRN Obstet Gynecol; 2012; 2012():325790. PubMed ID: 23209924
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
10. Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?
Marnitz S; Köhler C; Gharbi N; Kunze S; Jablonska K; Herter J
Strahlenther Onkol; 2018 Nov; 194(11):965-974. PubMed ID: 30112692
[TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings.
Maneschi F; Ceccacci I; Perugini A; Pane C; Simeone A; Manicone A
Arch Gynecol Obstet; 2012 Feb; 285(2):521-7. PubMed ID: 21779772
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
[TBL] [Abstract][Full Text] [Related]
14. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
